18
November

08:00 AM EST

Clinical Operations

Name: Clinical Operations & Clinical Trial Supply Chain Strategy Meeting East Coast 2024 (Boston)
Start: 2024-11-14T08:00
End: 2024-11-14T18:00
Location: Crowne Plaza, London Docklands

&

Clinical Trial Supply Chain

Strategy Meeting East Coast USA 2024

Effective integration of patient outcomes in clinical trial design, overcoming under-enrollment of ethnic minorities, employing RBQM, and deep learning to enhance your trial knowledge

Le Meridien Cambridge Boston

Our Event Starts In

–
days

–
hours

–
minutes

–
seconds

A MEETING EXPERIENCE UNLIKE ANY OTHER

Fresh Clinical Operations Insights

Tired of the same conference experience? Real discussions and genuine networking are often promised, but not always delivered. Proventa International’s Clinical Strategy Meetings are designed to avoid the pitfalls of a typical conference, by providing the right environment to make those important connections through interactive roundtable discussions, exclusive networking and keynote panel debates. Join Clinical Operations professionals from across the East Coast, in Boston MA, to discover new insights and take your company’s mission to the next level.

What makes our strategy meetings unique?

Roundtable Discussions

Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.

Unrivalled Networking

With senior delegation from big pharma and innovative biotech from across the East Coast, you can network with peers from different locations, all in one place.

Personalised Agenda

Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.

Solutions to your Problems

We've partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.

Industry Researched Topics

We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.

Senior Decision Makers

The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.

Meet Our 2024 Facilitators

Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at our Clinical Operations strategy meeting.

Abhishek Gupta

Senior Director, Research & Development | Quality Capabilities BlueRock Therapeutics

Allison Kemner

Vice President, Clinical Sciences and Operations Tyra Biosciences

Amy McCagg

Executive Director and Head, Patient Innovation Sarepta Therapeutics

AnneMarie Winkler

Associate Director, Clinical Trial Optimization and Innovation Genmab

Bill Jackson, Ph.D

Founder & CEO Base Pair Biotechnologies, Inc.

Caroline Potts

General Manager – MRN Site and Patient Services MRN

Charlie Pattrell

Associate Director, Solution Engineering IQVIA

Ed Carneglia

Business Development Manager Peli BioThermal USA

Frank Leu

Founder & Managing Member/ Managing Member BioPharMatrix LLC/ Novapeutics LLC

George Naumov

Chief Operations Officer & Chief Business Officer RS Oncology

Graham Wylie

Executive Chairman Medical Research Network

James Kirwin

COO and Head, Clinical Development Operations SFA Therapeutics

James Kirwin is a seasoned pharmaceutical executive with over 20 years industry experience and has been involved in more than 20 NDAs. He has experience at major pharmaceutical companies such as AstraZeneca where he was Clinical Operations Team Lead for the Nexium program. He was VP of Global Clinical Development Operations at Wyeth Pharmaceuticals for the 10 years prior to its acquisition by Pfizer. Since then, he has led Clinical Development Operations at several startups, Intrexon, Intercept Pharmaceuticals, Iterum Therapeutics and Arvinas. He has been responsible for many “firsts” in clinical trial operations. While leading Global Clinical Operations at Wyeth, he was the first to implement Electronic Data Capture across all studies in the company globally. He developed the concept of the Functional Service Provider Model with RPS, implementing a US based monitoring group and also developed back-office data management and Trial Master File support in Bangalore India in partnership with Accenture.

Jamie Morisco

Vice President, Sales, Marketing & Operations Glemser Technologies

Justin Buie

Clinical Program Manager Candel Therapeutics

Maria Margarita Corvez

Global Program Director Hematology AstraZenca

Meredith Frank-Molnia

Vice President, Clinical Affairs Vericel Corporation

Michael Kleinrock

Senior Research Director, IQVIA Institute for Human Data Science IQVIA

Michael Kleinrock serves as Research Director for the IQVIA Institute for Human Data Science, setting the research agenda for the Institute, leading the development of reports and projects focused on the current and future role of human data science in healthcare in the United States and globally. Kleinrock leads the research development included in Institute reports published throughout the year. The research is focused on advancing the understanding of healthcare and the complex systems and markets around the world that deliver it.
Throughout his tenure at IMS Health, which began in 1999, he has held roles in customer service, marketing, product management, and in 2006 joined the Market Insights team, which is now the IQVIA Institute for Human Data Science.
He holds a B.A. degree in History and Political Science from the University of Essex, Colchester, UK, and an M.A. in Journalism and Radio Production from Goldsmiths College, University of London, UK.

Michael Tolentino

Co-Founder, Chief Innovation Officer Aviceda Therapeutics

ML Ujwal

Associate Director, Data Science Johnson & Johnson

Nancy Dubois

Head, Global Patient Safety, US Region EMD Serono, Inc.

Naouel Baili

Director, AI Scientist IQVIA Technologies

Pawan Gandhi

Director, R&D Glemser

Rakibou Ouro-Djobo

Global Clinical Supply Chain & Logistics Leader Bill & Melinda Gates Medical Research Institute

Seshu Tyagarajan

Chief Technical and Development Officer Candel Therapeutics

Yuyi Shen

Vice President, Technical Operations Abcuro,Inc.

Yuyi Shen is an inspirational CMC thought leader with management experience in biopharmaceutical development, manufacturing, and clinical supply chain. She is an accomplished program leader in the early to late phase development and commercialization of a wide range of recombinant proteins for immuno-oncology, infectious and rare disease drug platforms. She brings extensive expertise in CDMO selection and oversight, facility/team build- out, technology transfer, budget planning, partner collaboration, and CMC strategic direction of global regulatory filings. She is also an industry-recognized innovation-driven CMC expert on disruptive technology implementation, including process modeling, to deliver with high efficiency and better quality under an accelerated timeline.
She served various leadership roles in CMC at large pharma to emerging biotech companies, including Bolt, XOMA, Bayer, BioMarin, and Grifols. She holds a Ph.D. degree in Chemical Engineering from the University of California, Davis.

Uday Harle

Assistant Vice President and Head, Global Clinical Research Kashiv Biosciences

First name	Last name	Job title	Company name	Photo URL	Bio Position
Abhishek	Gupta	Senior Director, Research & Development \| Quality Capabilities	BlueRock Therapeutics	https://proventainternational.com/wp-content/uploads/2024/08/Abhishek-Gupta.jpg	Abhishek is a senior data, business, and technology leader with more than 2 decades of experience in building and driving digital and transformation capabilities within the pharma and biotech environments. He is primarily recognized for enterprise perspective, technical acumen, and collaborative style. Abhishek currently heads up the strategic as well as operational aspects of digital capabilities and solutions for clinical development and quality assurance at BlueRock Therapeutics. Previously, Abhishek led diverse leadership roles across Sage Therapeutics and Vertex Pharmaceuticals. Abhishek holds a master’s in strategic management and a bachelor’s in CS & IT. He is also an MIT fellow for systems design and management.
Allison	Kemner	Vice President, Clinical Sciences and Operations	Tyra Biosciences	https://proventainternational.com/wp-content/uploads/2024/08/Allison-Kemner.jpg	As a clinical nurse scientist, Allison Kemner’s focus is grounded in patient-centered cancer care. and access to clinical trials. During her 20+ year career, she has held senior and executive positions in drug development at large and small companies pursuing operational excellence while delivering value to the business. She has been part of numerous submission teams. supporting multiple FIH INDs for novel NCE through to NDAs and sNDAs. For the last several years, her attention has been on instituting early collaboration with patients and advocates, ensuring their voices are present throughout clinical development.
Amy	McCagg	Executive Director and Head, Patient Innovation	Sarepta Therapeutics	https://proventainternational.com/wp-content/uploads/2024/11/Amy-McCagg.jpg	Amy McCagg, MBA, is a biopharmaceutical leader with over 20 years of drug development management, contributing to 7 approvals and label expansions. Ms. McCagg began her career leading the clinical operations for large cardiovascular outcomes trials with the TIMI Study Group. Following her transition into industry, she focused on rare diseases and highlighted the patient voice within clinical development and commercial. She spent the last 10 years leading teams within Sanofi-Genzyme, Rhythm Pharmaceuticals, and Sarepta Therapeutics to improve patient identification, include the patient perspective within protocols, and offer services to reduce barriers to clinical trial participation.
AnneMarie	Winkler	Associate Director, Clinical Trial Optimization and Innovation	Genmab	https://proventainternational.com/wp-content/uploads/2024/10/AnneMarie-Winkler.jpg	Business Lead for DEI in Clinical Trials. Lead for patient experience and patient-focused drug development across R&D. Prior to joining Genmab, I was Development Unit Lead for Patient Engagement, Equity & Transparency at Biogen, Manager Clinical Operations, Syneos Health/Merck, Indication Lead for Global Trial Optimization at Syneos Health/Merck, for End-to-End Feasibility and Recruitment in Tumor Agnostic Basket Studies, Novel Biomarkers, and Rare Diseases. During my time as Clinical Research Manager and IRB Administrator, Portsmouth Regional Hospital also served on New Hampshire’s Comprehensive Cancer Collaboration: Emerging Issues Work Group, Public Policy Education Committee Head of Human Rights Protections, and Patient Advocate at North Suffolk Mental Health.
Bill	Jackson, Ph.D	Founder & CEO	Base Pair Biotechnologies, Inc.	https://proventainternational.com/wp-content/uploads/2024/11/Bill-Jackson-1.jpg	As CEO of BasePair Biotechnologies, Bill has been leading the development and commercialization of aptamer-based diagnostics and therapeutics since 2012. In addition to private capital, Dr. Jackson has also secured significant non-dilutive funding through government grants and contracts as well as revenue from earlystage products and services. He has served as principal investigator on more than 20 federally funded research projects and established collaborations with clinicians and researchers at world-class research institutions and universities. Bill also serves frequently as a panel reviewer regarding molecular diagnostics and related tools, environmental monitoring, and biodefense. His stated mission is to leverage the potential of aptamers to create innovative solutions for global health and environmental challenges, and to advance the field of aptamer science and technology.
Caroline	Potts	General Manager – MRN Site and Patient Services	MRN	https://proventainternational.com/wp-content/uploads/2024/10/Caroline-Potts-1.jpg	Before joining MRN, Caroline worked in the public sector for 15 years supporting research in hospitals and the primary care setting as well as providing support to research academics by writing funding applications, making submissions to regulatory authorities and running a large portfolio of studies to ICH- GCP requirements in clinical specialties such as stroke medicine, Parkinson’s disease, orthopaedics, gastrointestinal medicine and respiratory medicine. During this time, Caroline was one of the founding members of the UKRD group as well as an Executive member of the RD Forum providing R&D Directors and research staff working in the public sector with strategic guidance in supporting high quality research in the NHS. In her current role, Caroline leads the development and expansion of MRN’s global site network, site training programs, and on-site support services.
Charlie	Pattrell	Associate Director, Solution Engineering	IQVIA	https://proventainternational.com/wp-content/uploads/2024/11/Charlie-Pattrell.jpg
Ed	Carneglia	Business Development Manager	Peli BioThermal USA	https://proventainternational.com/wp-content/uploads/2024/11/Ed-Carneglia.jpg
Frank	Leu	Founder & Managing Member/ Managing Member	BioPharMatrix LLC/ Novapeutics LLC	https://proventainternational.com/wp-content/uploads/2020/08/Frank-Leu-1.jpg	Frank Leu is a Founder & Managing Member/ Managing Member of BioPharMatrix LLC/ Novapeutics LLC located in Philadelphia, developing a first-in-class insulin-producing beta-cell restoration curative for diabetes. Prior, Frank was at a specialty pharma, Verto Institute, developing curatives for a neuroendocrine cancer. Frank received his Pharmacology Ph.D. from Weill Cornell Graduate School of Medical Sciences, postdoc-ed at a HHMI lab at the Rockefeller University, and served as an instructor at the Rutgers Cancer Institute of NJ. Currently, he is an adjunct professor at Thomas Jefferson University, advisor to 1776 for Pennovation Center Labs, founder of BioPharMatrix (life-science ecosystem), and serving on numerous life-sciences advisory boards.
George	Naumov	Chief Operations Officer & Chief Business Officer	RS Oncology	https://proventainternational.com/wp-content/uploads/2023/07/George-Naumov.jpg
Graham	Wylie	Executive Chairman	Medical Research Network	https://proventainternational.com/wp-content/uploads/2024/10/Graham-Wylie.jpg
James	Kirwin	COO and Head, Clinical Development Operations	SFA Therapeutics	https://proventainternational.com/wp-content/uploads/2024/02/James-Kirwin.jpg	James Kirwin is a seasoned pharmaceutical executive with over 20 years industry experience and has been involved in more than 20 NDAs. He has experience at major pharmaceutical companies such as AstraZeneca where he was Clinical Operations Team Lead for the Nexium program. He was VP of Global Clinical Development Operations at Wyeth Pharmaceuticals for the 10 years prior to its acquisition by Pfizer. Since then, he has led Clinical Development Operations at several startups, Intrexon, Intercept Pharmaceuticals, Iterum Therapeutics and Arvinas. He has been responsible for many “firsts” in clinical trial operations. While leading Global Clinical Operations at Wyeth, he was the first to implement Electronic Data Capture across all studies in the company globally. He developed the concept of the Functional Service Provider Model with RPS, implementing a US based monitoring group and also developed back-office data management and Trial Master File support in Bangalore India in partnership with Accenture.
Jamie	Morisco	Vice President, Sales, Marketing & Operations	Glemser Technologies	https://proventainternational.com/wp-content/uploads/2023/05/Jamie-Morisco.jpg	Jamie serves as a Director of Sales for Glemser. In this role, Jamie draws from his extensive background in technology and business transformation to assist clients along their modernization journey. Jamie has a proven track record leading clients and team through complex technology enabled transformations delivering benefits across time, quality, cost and compliance.
Justin	Buie	Clinical Program Manager	Candel Therapeutics	https://proventainternational.com/wp-content/uploads/2024/11/Justin-Buie.jpg
Maria	Margarita Corvez	Global Program Director Hematology	AstraZenca	https://proventainternational.com/wp-content/uploads/2024/07/Maria-Margarita-Corvez.jpg
Meredith	Frank-Molnia	Vice President, Clinical Affairs	Vericel Corporation	https://proventainternational.com/wp-content/uploads/2024/07/Meredith-Frank-Molnia.jpg	Meredith joined Vericel in 2024 with more than 25 years of experience in the clinical research industry. She most recently served as Senior Director of Clinical Operations at Third Pole Therapeutics. Prior to Third Pole, Meredith also held roles of increasing responsibility at Axiom Real-Time Metrics, Advanced Clinical, Smith & Nephew, and Stryker Biotech. Throughout her career, Meredith has been involved in various aspects of clinical operations, including project management, vendor selection, implementation of new technologies, and regulatory approvals. She holds a B.S. in Biology and German Literature
Michael	Kleinrock	Senior Research Director, IQVIA Institute for Human Data Science	IQVIA	https://proventainternational.com/wp-content/uploads/2024/08/Michael-Kleinrock.jpg	Michael Kleinrock serves as Research Director for the IQVIA Institute for Human Data Science, setting the research agenda for the Institute, leading the development of reports and projects focused on the current and future role of human data science in healthcare in the United States and globally. Kleinrock leads the research development included in Institute reports published throughout the year. The research is focused on advancing the understanding of healthcare and the complex systems and markets around the world that deliver it. Throughout his tenure at IMS Health, which began in 1999, he has held roles in customer service, marketing, product management, and in 2006 joined the Market Insights team, which is now the IQVIA Institute for Human Data Science. He holds a B.A. degree in History and Political Science from the University of Essex, Colchester, UK, and an M.A. in Journalism and Radio Production from Goldsmiths College, University of London, UK.
Michael	Tolentino	Co-Founder, Chief Innovation Officer	Aviceda Therapeutics	https://proventainternational.com/wp-content/uploads/2024/10/Michael-Tolentino-1.jpg
ML	Ujwal	Associate Director, Data Science	Johnson & Johnson	https://proventainternational.com/wp-content/uploads/2023/11/ML-Ujwal-Janssen.jpg	ML Ujwal PhD leads the PSTS/Data Science at Janssen R&D (J&J). He is a proven scientific leader with a strong pedigree in Drug Discovery and Applied Machine Learning. He has 15+ years of experience in academia, biotech, and large pharma. Before joining Janssen R&D, he co-founded and was the head of Data Sciences at Inciton, an early-stage startup that used MD simulations and ML approaches. Earlier he led predictive toxicology efforts at Eli Lilly & Co. He was on staff at the Institute for Genomic Research (TIGR). His academic credentials include MIT Engineering Management with an emphasis on systems thinking and ML frameworks. As an IIJMB Wood-Whelan fellow, he is a joint PhD in Computational Biochemistry/Biophysics from the Indian Institute of Science (IISc) and the University of Texas, Austin, followed by post-doctoral work both at Yale and Harvard. He has extensively published in peer-reviewed journals and serves on scientific advisory committees.
Nancy	Dubois	Head, Global Patient Safety, US Region	EMD Serono, Inc.	https://proventainternational.com/wp-content/uploads/2023/10/Nancy-Dubios.jpg	Dr. Nancy Dubois oversees Global Patient Safety for the US Region at EMD Serono. With over 20 years of expertise in healthcare and clinical trial research, she has held significant roles in both academic and sponsor environments. Over the past decade, Dr. Dubois has excelled in managing pharmacovigilance programs, implementing REMS ETASUs in healthcare settings, establishing compliant safety operations for US startups, and offering strategic insights to improve global collaboration and operational efficiency by dismantling silos. Her clinical training and extensive experience underscore her commitment to patient safety and innovation in the healthcare industry.
Naouel	Baili	Director, AI Scientist	IQVIA Technologies	https://proventainternational.com/wp-content/uploads/2024/04/Naouel-Baili.jpg	Naouel is an expert in emerging technology solutions, leveraging over ten years of experience in the life sciences industry to transform clinical trial management. Her proficiency in embedding sophisticated AI tools into SaaS platforms has significantly improved both user experience and operational efficiency. A holder of a Ph.D. in Computer Science, she excels in the development and design of innovative AI capabilities that streamline and optimize clinical research.
Pawan	Gandhi	Director, R&D	Glemser	https://proventainternational.com/wp-content/uploads/2023/05/Pawan-Gandhi.jpg	Pawan serves clients as the Director of Global Research and Development. He brings along extensive experience in designing and implementing enterprise compliance solutions for life sciences clients. Pawan directs and coordinates development activities for organizational products to deliver quality solutions catering to complex regulated use cases.
Rakibou	Ouro-Djobo	Global Clinical Supply Chain & Logistics Leader	Bill & Melinda Gates Medical Research Institute	https://proventainternational.com/wp-content/uploads/2024/07/Rakibou-Ouro-Djobo.jpg	Rakib Ouro-Djobo is a visionary supply chain leader with over 15 years of experience driving global impact in life sciences and biotechnology. As the Clinical Supply Chain Lead at the Bill & Melinda Gates Medical Research Institute, he leverages and implements innovative supply chain strategies that streamline clinical trial materials (CTM), packaging, and labeling for global distribution. His leadership has been instrumental in advancing cutting-edge storage technologies and fostering global networks that ensure the seamless delivery of life-saving treatments, particularly in low-income countries. Rakib is committed to leveraging his expertise to transform clinical supply chains and accelerate worldwide access to critical health interventions.
Seshu	Tyagarajan	Chief Technical and Development Officer	Candel Therapeutics	https://proventainternational.com/wp-content/uploads/2023/02/Seshu-Tyagarajan-2.jpg	Dr. Seshu Tyagarajan is the Chief Technical and Development Officer at Candel Therapeutics. She has two decades of technical, manufacturing and development experience in Biologics and Cell & Gene therapies. Prior to Candel, she was Global Head, CMC Strategy for CGT at Novartis where she developed the clinical and commercial manufacturing strategy for T-Charge™(CAR-T). She successfully led several BLAs and INDs and was a key contributor to the groundbreaking BLA submission for Kymriah®. Seshu held roles of increasing responsibility at Merck, Roche, Phyton, Biogen and Lilly. She holds a Ph.D. in Chemical and Biochemical Engineering (Rutgers), and MS in Bioengineering (Purdue).
Yuyi	Shen	Vice President, Technical Operations	Abcuro,Inc.	https://proventainternational.com/wp-content/uploads/2020/04/Yuyi-Shen.jpg	Yuyi Shen is an inspirational CMC thought leader with management experience in biopharmaceutical development, manufacturing, and clinical supply chain. She is an accomplished program leader in the early to late phase development and commercialization of a wide range of recombinant proteins for immuno-oncology, infectious and rare disease drug platforms. She brings extensive expertise in CDMO selection and oversight, facility/team build- out, technology transfer, budget planning, partner collaboration, and CMC strategic direction of global regulatory filings. She is also an industry-recognized innovation-driven CMC expert on disruptive technology implementation, including process modeling, to deliver with high efficiency and better quality under an accelerated timeline. She served various leadership roles in CMC at large pharma to emerging biotech companies, including Bolt, XOMA, Bayer, BioMarin, and Grifols. She holds a Ph.D. degree in Chemical Engineering from the University of California, Davis.
Uday	Harle	Assistant Vice President and Head, Global Clinical Research	Kashiv Biosciences	https://proventainternational.com/wp-content/uploads/2024/04/Uday-Harle.jpg	Uday Harle is a global clinical development leader with two decades of experience as Ex-Global Head at Abbott, Ferring Pharma, and is presently serving Kashiv Bioscience and an associated group of companies. PhD in medicine with many research publications, awards, and scientific text book authors.

Abhishek Gupta, Allison Kemner, Amy McCagg, AnneMarie Winkler, Bill Jackson, Ph.D, Caroline Potts, Charlie Pattrell, Ed Carneglia, Frank Leu, George Naumov, Graham Wylie, James Kirwin, Jamie Morisco, Justin Buie, Maria Margarita Corvez, Meredith Frank-Molnia, Michael Kleinrock, Michael Tolentino, ML Ujwal, Nancy Dubois, Naouel Baili, Pawan Gandhi, Rakibou Ouro-Djobo, Seshu Tyagarajan, Yuyi Shen, Uday Harle

Europe

USA East

USA West

Webinars

Dinners & Spotlights

R&D

Clinical Trials Boston

Clinical Operations & Clinical Trial Supply Chain Strategy Meeting East Coast – Boston 2024

&

Strategy Meeting East Coast USA 2024

<img class="lazy" decoding="async" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://proventainternational.com/wp-content/uploads/2020/12/location.png" >Le Meridien Cambridge Boston

Fresh Clinical Operations Insights

What makes our strategy meetings unique?

Roundtable Discussions

Unrivalled Networking

Personalised Agenda

Solutions to your Problems

Industry Researched Topics

Senior Decision Makers

Meet Our 2024 Facilitators

Abhishek Gupta

Allison Kemner

Amy McCagg

AnneMarie Winkler

Bill Jackson, Ph.D

Caroline Potts

Charlie Pattrell

Ed Carneglia

Frank Leu

George Naumov

Graham Wylie

James Kirwin

Jamie Morisco

Justin Buie

Maria Margarita Corvez

Meredith Frank-Molnia

Michael Kleinrock

Michael Tolentino

ML Ujwal

Nancy Dubois

Naouel Baili

Pawan Gandhi

Rakibou Ouro-Djobo

Seshu Tyagarajan

Yuyi Shen

Uday Harle

Who Should Attend the Event?

Clinical Operations

Clinical Project/ Program Leads

Clinical Quality Assurance

Clinical Research

Clinical Outsourcing

Data Management

Vendor Management

Medical/Scientific Officers

Biometrics

Medical Affairs

Patient affairs

Global study

Site management/ selection

Digital health

TMF/eTMF

Data monitoring

Patient recruitment

Patient engagement

Clinical investigation

Study optimisation

Patient insights

Clinical systems

See Which Topics Are Discussed at the Strategy Meeting

Breakfast & Registration

Opening Keynote Presentation

Roundtable

Roundtable Tracks

REFRESHMENT BREAK

NETWORKING / 1-1 MEETINGS

NETWORKING / 1-1 MEETINGS

NETWORKING / 1-1 MEETINGS

Roundtable

Roundtable Tracks

Le Meridien Cambridge Boston

Clinical Operations &
Clinical Trial Supply Chain
Strategy Meeting Europe 2026

Medicinal Chemistry
Drug Discovery Biology & Bioinformatics
Strategy Meeting Europe 2026